Dharmanol™ is an all-natural fire fighter. The  study

New Post Public Reply Private Reply Replies (1) Message Board
bellsandwhistles
Dharmanol™ is an all-natural fire fighter. The  study published in Lancet on the disease effects of chronic inflammation is worth millions to SK.  Non-psychoactive Dharmanol is a powerful anti-inflammatory herbal supplement. The broad synergistic spectrum of cannabinoids  (not only CBD) and terpenes in Dharmanol are known to block inflammation.

Peer-reviewed British medical journal Lancet (British equivalent of JAMA ) has published a study linking coronary disease (#1 killer in US) to chronic inflammation. In fact, there is a growing body of thought and evidence in medical research that chronic inflammation may be the root cause of many diseases.

British journal "Lancet" has therefore supplied yet another strong reason why Dharmanol™, with its array of
powerful anti-inflammatory ingredients that naturally quell physiological inflammation, may be a blockbuster product.


National Cancer Institute: "CBD, in particular, is thought to have significant analgesic and anti-inflammatory activity without the psychoactive effect (high) of delta-9-THC."

Lancet study:  http://www.thelancet.com/journals/laninf/arti...10)70029-3

Yahoo Health |
Inflammation: The Root Cause of All Disease?


"In a medical version of the 'unified field' theory in physics, many scientists now believe that most—or perhaps all—chronic diseases may have the same trigger: inflammation. This fiery process has been linked to everything from heart attacks and strokes to type 2 diabetes, Alzheimer’s disease, and even cancer. "

By Lisa Collier Cool
Jan 16, 2013

In a medical version of the “unified field” theory in physics, many scientists now believe that most—or perhaps all —chronic diseases may have the same trigger: inflammation. This fiery process has been linked to everything from heart attacks and strokes to type 2 diabetes, Alzheimer’s disease, and even cancer.

Chronic, low-grade systemic inflammation—fueled by such disorders as excessive belly fat, poor diet, lack of exercise, smoking, and gum disease—may explain why lifestyle-linked diseases have reached epidemic levels in Western countries, while remaining rare in the developing world.

“There are clear indications that inflammation explains why plaque builds up in the arteries in patients with atherosclerosis,” says Philip Schauer, MD, director of the Bariatric and Metabolic Institute at the Cleveland Clinic. “Chronic inflammation also plays a direct role in diabetes, high blood pressure, sleep apnea, asthma and many other conditions.”

The Missing Puzzle Piece

Two groundbreaking new studies published in Lancet suggest that fire inside the artery walls could be the missing puzzle piece to solve the mystery of why many people with normal or even optimal cholesterol levels suffer heart attacks or strokes, while others with very high cholesterol never develop heart disease.

The studies were the first to show a cause-and-effect relationship between a specific inflammatory marker (interleukin 6, also known as IL-6) and heart disease risk—a discovery that could lead to revolutionary new therapies to treat or prevent the leading killer of Americans.

The researchers pooled data from nearly 135,000 people and found that those with a gene variant linked to a lower-than-normal number of IL-6 receptors were much less likely to develop heart disease, even though they had the same rates of smoking, diabetes, high cholesterol, and other risk factors as people without this variant.

The findings suggest that medication to block IL-6 receptors—currently used to treat rheumatoid arthritis (also an inflammatory disease)—could be a new weapon against heart disease.

Is Your Body on Fire?

Most of the time, inflammation protects health. If you stepped on a nail, your body would mobilize immune system troops to battle the invading bacteria by releasing signaling molecules, such as IL-6, to launch the inflammatory cascade. The immune system reaction involves more than 20 proteins that blast the invaders with chemicals to kill them, along with an assortment of odd-looking white blood cell components that resemble characters from Creepshow2.

The result of this immune system response is the familiar feeling of redness and warmth around the wound as it starts to heal. Chronic inflammation, however, harms rather than heals, because the immune system attack never stops. It’s like being shot by “friendly fire” during a perpetual war raging inside the body, says Dr. Schauer.

The #1 Warning Sign of Chronic Inflammation

The easiest way to tell if your body—and arteries—might be on fire is to measure your waist. A circumference above 35 inches for a woman or 40 inches for a man means you could be at risk for a variety of dangerous diseases linked to chronic inflammation, even if your weight is normal.

“Excessive visceral fat is very different than fat in other parts of the body,” says Dr. Schauer. “Abdominal fat cells are much more biologically active than subcutaneous fat cells, releasing several hormones and cytokines [chemical messengers involved in immune system and inflammatory responses]. There is also a genetic component to both chronic inflammation and obesity—it’s not just an unhealthy lifestyle that leads to these problems.”

A big belly is also the leading indicator of metabolic syndrome, a gang of five metabolic thugs that quintuple risk for type 2 diabetes and triple it for heart attack. Fifty million Americans, many of whom are undiagnosed, suffer from this dangerous disorder.

If you have three or more of the following disorders, you have metabolic syndrome:

A large waistline. This also is called "an apple shape."
High triglycerides: a level of this blood fat above 150 mg/dL
Low HDL (less than 50 mg/dL for women and less than 40 mg/dL for men). HDL is the good cholesterol that keeps the heart and brain healthy.
High blood pressure: 130/85 mmHg or higher (or you’re on blood pressure medicine).
High fasting blood sugar: 100 mg/dL or above  (or you're on medicine to treat high blood sugar).

Can Targeting Inflammation Improve Alzheimer’s Disease?

Many studies have linked Alzheimer’s disease—also called “type 3 diabetes”—to chronic inflammation. A new study published in Nature Medicine reports that in mice with the memory-robbing disorder, levels of pro-inflammatory cytokines called IL-12 and IL-23 soar.

When the animals’ brains were treated with antibodies that target IL-12 and Il-23, their memory deficits were actually “reversed,” the researchers report, suggesting that anti-inflammatory therapies may help combat the disease’s progression.

Another new study found that statins—which are known to have potent anti-inflammatory effects in people—boosted memory in mice in the early stages of Alzheimer’s. The statin used in the study was simvastin (Zocor).

However, medication isn’t the only fire-fighter; research also shows that regular exercise helps keep both the body and brain healthy. Interval training, in particular, is one of the best ways to slim your waist—and put out the fire in your belly.
http://health.yahoo.net/experts/dayinhealth/i...ll-disease

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Couche-Tard's Q1 2027: Strong Growth Amid Challenges

Updated Category News Views 9

Decoding Alimentation Couche-Tard's Recent Gains When the talk in the finance circles centers around Alimentation Couche-Tard (TSX: ATD) these days, it's all about their jump into fiscal 2027. The giant convenience store operator dished out some promising numbers for their first quarter, rippling through Wall Street's coffee breaks. Net earnings for shareholders of $828.5...

Continue Reading
Penn State-Battalion Pact Advances Semiconductor and Alloy Tech

Updated Category News Views 16

Bridging Academia and Industry for Security Every so often, academia and industry find that sweet spot where their paths align. It's one of those days, it seems. Penn State University and Battalion Advanced Technology Ltd have cozied up for some big-ticket collaboration on materials research. They're not simply tossing money around—up to $6 million's earmarked for two...

Continue Reading
Check Point Shareholders Back 2026 AGM Proposals

Updated Category News Views 0

Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...

Continue Reading
Costa Rica's Summit Draws Global Investors, Buyers

Updated Category News Views 0

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

Continue Reading
Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 2

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading
Replay Sports Cards Expands to Greenville With New Franchise

Updated Category News Views 0

An Old Hobby Gets New Life in Greenville Isn't it something when a hobby from your childhood eventually morphs into a business venture? That's exactly what's happening in Greenville, North Carolina, where Replay Sports Cards is laying down roots. Thanks to Jim and Jake Whitehurst's fresh franchise agreement, the card community along the eastern seaboard is about to have a...

Continue Reading
MD Integrations' Bold Cert Link: Telehealth's New Era

Updated Category News Views 1

MD Integrations Paves a New Path in Telehealth Well, folks, it seems someone’s finally listening. MD Integrations is taking a serious swing at solving one of telehealth's big hiccups – compliance delays. By roping in LegitScript directly, they’re all set to smooth the rocky road to launching virtual care brands. The Sticky Issue of Compliance Delays Anyone dabbling...

Continue Reading
York Urged to Retire Research Macaques After Probe

Updated Category News Views 0

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Continue Reading
NEXA Unlimited: Disrupting Mortgage Broker Earnings

Updated Category News Views 7

What Exactly Is NEXA Unlimited? In a game-changer twist, NEXA Lending has launched something that could dramatically shuffle the current mortgage broker model deck. Dubbed NEXA Unlimited, this new model promises no less than 100% revenue access to its loan officers. We're talking zero fees—flat, funding, closing—none of ‘em. This isn't a small tweak or a cosmetic...

Continue Reading
Marco's Pizza Fuels Education with $1M Donation Boost

Updated Category News Views 1

It's not just about slinging pies for Marco's Pizza these days. They're marking a mighty milestone with a $1 million donation to Junior Achievement USA, a major player in prepping young folks to grapple with real-world financials and entrepreneurship. This hefty check not only pushes The Marco's Pizza Foundation's giving tally past the $1.5 million mark, but it also...

Continue Reading

Top 5 Most Recently Viewed Articles

Tempus AI: Important Legal Reminder for Investors

Updated Category News Views 112

Understanding Tempus AI's Legal Situation Tempus AI, Inc. has recently found itself at the center of a legal storm, and it's crucial for investors to be aware of the developments that could impact their interests. Bragar Eagel & Squire, P.C., a well-respected law firm, has been actively engaging with shareholders who have experienced losses. How Tempus AI Investors Can...

Continue Reading
Projected Growth of the Fatty Amines Market to $4.97 Billion

Updated Category News Views 214

Overview of the Fatty Amines Market The fatty amines market is poised for significant growth, with projections indicating an increase from USD 3.60 billion in 2025 to USD 4.97 billion by 2030. This growth, reflecting a compound annual growth rate (CAGR) of 6.7%, is attributed to heightened demand across various sectors. The Influence of Eco-friendly Practices As...

Continue Reading
NIP Group Finalizes Major Crypto Mining Assets Acquisition

Updated Category News Views 130

NIP Group Inc. Completes New Acquisition in Crypto Mining NIP Group Inc. (NASDAQ: NIPG), a trailblazer in the digital entertainment industry, has successfully finalized a significant acquisition of on-rack crypto mining machinery. This strategic move is designed to enhance their operational capacity, enabling them to accelerate growth in the crypto asset sector. Details...

Continue Reading
Understanding the Altimmune Class Action Lawsuit for Investors

Updated Category News Views 189

The Class Action Lawsuit Against Altimmune Investors affected by the recent events surrounding Altimmune (NASDAQ: ALT) have an opportunity to participate in an important class action lawsuit. The lawsuit was launched by Bragar Eagel & Squire, P.C., a renowned law firm specializing in stockholder rights. It pertains to all individuals who acquired securities of Altimmune...

Continue Reading
Koryx Copper's Promising Drill Insights Reveal Project Growth

Updated Category News Views 275

Exciting Drill Results from Koryx Copper's Haib Project Koryx Copper Inc. (TSX-V: KRY) has recently unveiled assay results that are making waves in the mining community. These results are derived from an active and promising drill program at the Haib Copper Project. This ongoing effort is part of Koryx’s strategy for exploration and project development. The current...

Continue Reading